Fish oil treatment of interferon-alpha-induced dyslipidaemia: Study in patients with chronic hepatitis C

BioDrugs

Volumn 11, Issue 4, 1999, Pages 285-291

  Malaguarnera, Mariano ^a   Restuccia, Nunzio ^b   Di Fazio, Ignazio ^b   Panebianco, Maria Pia ^b   Gulizia, Giuseppe ^b   Giugno, Ignazio ^b  

^a CANNIZZARO HOSPITAL   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; FISH OIL; OMEGA 3 FATTY ACID;

ADULT; ARTICLE; CHRONIC HEPATITIS; DISEASE ASSOCIATION; DRUG EFFECT; DYSLIPIDEMIA; FEMALE; HEPATITIS C; HUMAN; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0032923733     PISSN: 11738804     EISSN: None     Source Type: Journal    
DOI: 10.2165/00063030-199911040-00007     Document Type: Article

References (62)

1. 1. Malaguarnera M, Di Fazio I, Ferlito L, et al. Comparison of four types of interferon alpha in the treatment of chronic hepatitis C. Curr Ther Res 1998; 59: 48-59
2. 2. Malaguarnera M, Di Fazio I, Restuccia S, et al. Efficacy of different schedules in the management of chronic hepatitis C with interferon alpha. Ann Med 1998; 30: 213-7
3. 3. Malaguarnera M, Restuccia S, Trovato G, et al. Interferon alpha treatment in patients with chronic hepatitis C. A meta analytic evaluation. Clin Drug Invest 1995; 9: 141-9
4. 4. Spath-Schwable E, Porzsolt F, Digel W, et al. Elevated plasma cortisol levels during interferon-α treatment. Immunopharmacology 1989; 17: 141-7
5. 5. Memon RA, Freingold VR, Moser AN, et al. In vivo effects of interferon-alpha and interferon-gamma on lipolysis and ketogenesis. Endocrinology 1992; 131: 1695-702
6. 6. Hudes BK, Cheathan AK, Sanyal AJ, et al. Interferon causes elevation of serum triglycerides during the treatment of chronic hepatitis C [abstract). Gastroenterology 1993; 104: A918
7. 7. Malaguarnera M, Giugno I, Trovato BA, et al. Lipoprotein (a) concentration in patients with chronic active hepatitis C before and after interferon treatment. Clin Ther 1995; 17: 721-9
8. 8. Grunfeld C, Kotler DP, Shigenaga JK, et al. Circulating IFN alpha levels and hypertriglyceridemia in the acquired immunodeficiency syndrome. Am J Med 1991; 90: 154-62
9. 9. Lebovics E, Antonecchia P, Clark S, et al. Relationship of serum triglyceride (TG) levels and response to α-interferon (α-IFN) in patients with chronic hepatitis C (CHC) [abstract). Gastroenterology 1993; 104: A935
10. 10. Malaguarnera M, Giugno I, Ruello P, et al. Effect of interferon on blood lipids. Clin Drug Invest 1996; 11 (1): 43-8
11. 11. Beutler BA, Cerami A. Recombinant interleukin 1 suppresses lipoprotein lipase activity in 3T3-L1 cells. J Immunol 1985; 135: 3969-71
12. 12. Saxena U, Witte LD, Goldberg IJ. Tumor necrosis factor induced release of endothelial cell lipoprotein lipase. Atheriosclerosis 1990; 10: 470-3
13. 13. Nordoy A, Hatcher F, Ullmann DL, et al. Individual effects of dietary saturated fatty acids and fish oil on plasma lipids and lipoproteins in normal men. Am J Clin Nutr 1993; 57 (5): 634-9
14. 14. Blok WL, Katan MB, van der Meer JW. Modulation of inflammation and cytokine production by dietary (n-3) fatty acids. J Nutr 1996; 126: 1515-33
15. 15. Meydani SN. Modulation of cytokine production by dietary polyunsaturated fatty acids. PSEBM 1992; 200: 189-93
16. 16. Harris WS. Dietary fish oil and blood lipids. Curr Opin Lipidol 1996; 7 (1): 3-7
17. 17. Torp-Pedersen S, Vyberg M, Smith E, et al. Surecut 0.6mm liver biopsy in the diagnosis of cirrhosis. Liver 1990; 10: 217-20
18. 18. Desmet VJ, Gerber M, Hoofnagle JH, et al. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994, 19: 1513-20
19. 19. Ishac K, Baptista A, Branchi I, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696-9
20. 20. Scheuer PJ, Davies SE, Dhillon AP. Histopathological aspects of viral hepatitis. J Viral Hep 1996, 3: 277-83
21. 21. Becker-Andre M, Hahlbrock K. Absolute mRNA quantification using the polymerase chain reaction (PCR): a novel approach by a PCR aided transcript titration assay (PATTY). Nucleic Acids Res 1989; 17: 9437-46
22. 22. Hagiwara H, Hayashi N, Mita E, et al. Quantitative analysis of hepatitis C virus RNA in serum during interferon alfa therapy. Gastroenterology 1993; 104: 877-83
23. 23. Hagiwara H, Hayashi N, Mita E, et al. Quantitation of hepatitis C virus RNA in serum of asymptomatic blood donors and patients with type C chronic liver disease. Hepatology 1993; 17: 545-50
24. 24. Okamoto H, Sugiyama Y, Okada S, et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol 1992; 73: 673-9
25. 25. Wahlefeld AW. Triglycerides determination after enzymatic hydrolysis. In: Bergmeyer HU, editor. Methods of enzymatic analysis. New York: Academic Press, 1974; 4: 1831-5
26. 26. Lopez-Virella MF, Stone P, Ellis S, et al. Cholesterol determination in high density lipoproteins separated by three different methods. Clin Chem 1977; 23: 882-4
27. 27. McNamara JR, Schafer EJ. Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions. Clin Chim Acta 1987; 166: 1-8
28. 28. Friedwald WT, Levi RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502
29. 29. Sironi M, Breviario F, Prosepio P. II-1 stimulates IL-6 production in endothelial cells. J Immunol 1989; 142: 549-53
30. 30. Kihase M, May LT, Tamm I. A cytokine network in human diploid fibroblasts: interactions of beta-interferon, tumor necrosis factor, platelet derived factor and IL-1. Mol Cell Biol 1987; 7: 273-80
31. 31. Scuderi P, Sterling KE, Raitano AB, et al. Recombinant interferon-α stimulates the production of human tumor necrosis factor in vitro. J Int Res 1987; 7: 155-64
32. 32. Haq AU, Rinehart JJ, Maca RD. The effect of gamma interferon on IL-1 secretion of in vitro differentiated human macrophages. J Leukocyte Biol 1985; 38: 735
33. 33. Jablons D, Nordan RP, McIntosh J, et al. Interleukin 6 inhibits adipocyte lipoprotein lipase activity in vivo and in vitro [abstract]. FASEB J 1990; A1713
34. 34. Patton JS, Shepard M, Wilking H, et al. Interferons and tumor necrosis factor have similar catabolic effects on 3T3 L 1 cells. Proc Natl Acad Sci USA 1986; 83: 8313-7
35. 35. Feingold KR, Soued M, Adi S, et al. Effect of IL-1 on lipid metabolism in the rat. Similarities to and differences from TNF. Arterioscler Thromb 1991; 11: 495-500
36. 36. Dyeberg J, Bang HO. A hypothesis on the development of acute myocardial infarction in Greenlanders. Scand J Clin Lab Invest 1982; 42 Suppl. 161: 7-13
37. 37. Kromann N, Green A. Epidemiological studies in the Upernavik Districk, Greenland. Acta Med Scand 1980; 208: 401-6
38. 38. Dyeberg J, Bang HO, Hjorne N. Fatty acid composition of the plasma lipids in Greenland Eskimos. Am J Clin Nutr 1975; 28: 958-66
39. 39. Bang HO, Dyeberg J, Hjorne N. The composition of food consumed by Greenland Eskimos. Acta Med Scand 1976; 200: 69-73
40. 40. Fredrikson DS. An international classification of hyperlipidemias and hyperlipoproteinemias [editorial]. Bull World Health Organ Ann Int Med 1971; 75: 471
41. 41. Daggy B, Arost C, Bensadoun A. Dietary fish oil decreased VLDL production rates. Biochim Biophis Acta 1987; 920: 293-300
42. 42. Cahill PD, Sarris E, Cooper AD, et al. Inhibiton of vein graft intimal thickening: reduced thromboxane production without change in lipoprotein levels or low density receptor density. J Vasc Surg 1988; 7: 108-18
43. 43. Loscalzo J, Freedman J, Rudd MA, et al. Unsaturated fatty acids enhance LDL uptake and degradation by peripheral blood mononuclear cell. Arteriosclerosis 1987; 7: 450-5
44. 44. Marsh JB, Topping DL, Nestel PJ. Comparative effects of fish oil and carbohydrate on plasma lipids and hepatic activities of phosphatidate phosphorylase, diacylglycerol acyltransferase and neutral lipase activities in the rat. Biochim Biophys Acta 1987; 922: 239-43
45. 45. Rustan AC, Nossen JO, Osmundsen H, et al. Eicosapentaenoic acid inhibits cholesterol esterification in cultured parenchymal cells and isolated microsomes from rat liver. J Biol Chem 1988; 263: 8126-32
46. 46. Iritani N, Fukuda E, Inoguchi K, et al. Reduction of lipogenic enzymes by shell fish triglycerides in rat liver, J Nutr 1980; 110: 1664-70
47. 47. Nassar BA, Huang YS, Manku MS, et al. The influence of dietary manipulation with n-3 and n-6 fatty acids on liver and plasma phospholipid fatty acids in rats. Lipid 1986; 21: 652-6
48. 48. Rustan AC, Nossen JO, Christiansen EN, et al. EPA reduces hepatic synthesis and secretion of triacylglycerol by decreasing the activity of acyl-coenzyme A: 1,2-diacylglycerol acyltransferase. J Lipid Res 1988; 29: 1417-26
49. 49. De Schrijver R, Privett OS. Effect of dietary long-chain fatty acids on the biosynthesis of unsaturated fatty acids in the rat. J Nutr 1982; 112: 619-26
50. 50. Rustan AC, Christiansen EN, Drevon CA. Serum lipids, hepatic glycerol metabolism and peroxisomal fatty acid oxidation in rats fed w-3 and 2-6 fatty acids. Biochem J 1992; 283: 333-9
51. 51. Harris WS, Connor WE, Illingworth DR, et al. The mechanism of the hypotriglyceridemic effect of dietary omega-3 fatty acids in man. Clin Res 1984; 32: 560A
52. 52. Phillipson BE, Rothrock DW, Connor WE, et al. Reduction in plasma lipids, lipoprotein, and apoprotein by dietary fish oil in patients with hypertriglyceridemia. N Engl J Med 1985; 312: 1210-24
53. 53. Entenman C. General procedures for separating lipid components of tissue. Methods Enzymol 1957; 3: 299-317
54. 54. Endres S, Ghorbani R, Kelley VE, et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 1989; 320: 265-71
55. 55. Meydani SN, Endres S, Woods MM, et al. Oral n-3 fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: comparison between young and older women. J Nutr 1991; 121: 547-55
56. 56. Dinarello CA, Endres S, Meydani SN, et al. Interleukin-1, anorexia, and dietary fatty acids. Ann N Y Acad Sci USA 1990; 587: 332-8
57. 57. Gallai V, Sarchielli P, Trequattrini A, et al. Cytokine secretion and eicosanoid production in the peripheral blood mononuclear cells of MS patients undergoing dietary supplementation with n-3 polyunsaturated fatty acids. J Neuroimmunol 1995; 56: 143-53
58. 58. Hellerstein MK, Wu K, McGrath M, et al. Effects of dietary n-3 fatty acid supplementation in men with weight loss associated with the acquired immune deficiency syndrome. Relation to indices of cytokine production. J Acquir Immune Refic Syndr Hum Retrovirol 1996; 11: 258-70
59. 59. Endres S, Meydani SN, Dinarello CA. Effects of omega-3 fatty acid supplements on ex-vivo synthesis of cytokines in human volunteers. Comparison with aspirin and ibuprofen. World Rev Nutr Diet 1991; 66: 401-6
60. 60. Renz H, Gong JH, Schmidt A, et al. Release of tumor necrosis factor-SYMBOI, 97/f 'Symbol' /s 13 from macrophages. Enhancement and suppression are dose-dependently regulated by prostaglandin E2 and cyclic nucleotides. J Immunol 1988; 141: 2388-93
61. 61. Andreone P, Cursaro C, Gasbarrini G. Interferon alpha increases prostaglandin E2 production by cultured liver biopsy in patients with chronic viral hepatitis: can non steroidal anti inflammatory drugs improve the therapeutic response to interferon? J Hepatol 1993; 19: 228-31
62. 62. Meydani SN, Dinarello CA. Influence of dietary fatty acids on cytokine production and its clinical implications. Nutr Clin Pract 1993; 8: 65-72